Publication:
SO-11 Bemarituzumab for treatment of previously untreated advanced and/or metastatic gastric and gastroesophageal cancer (GC): Final analysis of a randomized phase 2 trial (FIGHT)

Simple item page
dc.contributor.authorZ. Wainberg
dc.contributor.authorY. Kang
dc.contributor.authorK. Lee
dc.contributor.authorS. Qin
dc.contributor.authorK. Yamaguchi
dc.contributor.authorI. Kim
dc.contributor.authorA. Saeed
dc.contributor.authorS. Oh
dc.contributor.authorJ. Li
dc.contributor.authorH. Turk
dc.contributor.authorA. Teixeira
dc.contributor.authorE. Hitre
dc.contributor.authorA. Udrea
dc.contributor.authorG. Cardellino
dc.contributor.authorR. Guardeño Sanchez
dc.contributor.authorA. Zahlten-Kümeli
dc.contributor.authorK. Taylor
dc.contributor.authorP. Enzinger
dc.contributor.institutionauthorTÜRK, HACI MEHMET
dc.date.accessioned2026-10-25T13:40:38Z
dc.date.issued2023-06-01
dc.identifier.doi10.1016/j.annonc.2023.04.483
dc.identifier.issn0923-7534
dc.identifier.startpageS166
dc.identifier.urihttps://doi.org/10.1016/j.annonc.2023.04.483
dc.identifier.urihttps://hdl.handle.net/20.500.12645/42759
dc.identifier.volume34
dc.identifier.wos001037960400435
dc.language.isoen
dc.publisherElsevier BV
dc.relation.ispartofAnnals of Oncology
dc.rightsopenAccess
dc.sourceOpenAire
dc.titleSO-11 Bemarituzumab for treatment of previously untreated advanced and/or metastatic gastric and gastroesophageal cancer (GC): Final analysis of a randomized phase 2 trial (FIGHT)en
dc.typeArticle
dspace.entity.typePublication
local.indexed.atWOS
relation.isAuthorOfPublication1b3a1540-7e57-405d-8a9d-f926d17dcc29
relation.isAuthorOfPublication.latestForDiscovery1b3a1540-7e57-405d-8a9d-f926d17dcc29

Files

Collections

Yayınlar - Eserler